Although it is established that mutations in APOE, APP, PSEN1/2, and BACE1 contribute to AD risk [77, 78], and that the APOE-ε4 allele affects cognitive function [77, 79], known genetic variation alone explains only a small proportion of AD. This evidence concerns the gene BACE1 and Alzheimer disease.